Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Fitzgerald (Vancouver, BC, Canada). Emerging biologic approaches for the treatment of difficult to control asthma. International Congress 2017 – Pathophysiology and emerging therapies for severe asthma

Member's Comments

No comment yet.

Related content which might interest you: Who should receive which biologic and why? Current and future approaches in severe asthma patients Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what? Year: 2021 Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 A pragmatic guide to choosing biologic therapies in severe asthma Source: Breathe, 17 (4) 210144; 10.1183/20734735.0144-2021 Year: 2021 A new combination therapeutic approach challenging the current dogma of using inhaled corticosteroids as maintenance only to control asthma Source: Eur Respir J 2006; 28: Suppl. 50, 666s Year: 2006 Comparative efficacy of the therapy strategies for the asthma control maintenance in real clinical practice Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011 New and future developments of therapy for asthma in children Source: Eur Respir Mon 2012; 56: 224-234 Year: 2012 A new perspective on concepts of asthma severity, control and optimum treatment Source: Eur Respir J 2009; 33: 704-705 Year: 2009 Do we need new therapies for noneosinophilic asthma? Source: Annual Congress 2004 - Noneosinophilic asthma Year: 2004 Current and emerging approaches to the genetic diagnosis of chILDs Source: International Congress 2014 – Interstitial lung disease (ILD) in children Year: 2014 Current opinion: Pharmacological approaches in asthma and COPD Source: Breathe 2009; 6: 24-35 Year: 2009 Recommendations of new therapies for severe asthma and the future Source: Annual Congress 2013 –ERS/ATS Task Force report on severe asthma Year: 2013 Improving asthma therapy through targeting more effective control of inflammation - a European consensus Source: Eur Respir J 2005; 26: Suppl. 49, 253s Year: 2005 The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity Source: Eur Respir J, 52 (5) 1800694; 10.1183/13993003.00694-2018 Year: 2018 Identifying patients with severe asthma that will be benefit from biological therapy Source: Virtual Congress 2020 – Rethinking asthma Year: 2020 Pharmacological strategies for self-management of asthma exacerbations Source: Eur Respir J 2006; 28: 182-199 Year: 2006 Difficult-to-treat asthma : a multidimensional approach before considering targeted therapy Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019